cyclosporine has been researched along with Purpura, Thrombotic Thrombocytopenic in 56 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (32.14) | 18.2507 |
2000's | 26 (46.43) | 29.6817 |
2010's | 9 (16.07) | 24.3611 |
2020's | 3 (5.36) | 2.80 |
Authors | Studies |
---|---|
Hanamura, I; Horio, T; Iida, Y; Kanasugi, J; Matsuhisa, A; Matsumoto, M; Matsumura, S; Mizuno, S; Murakami, S; Nakamura, A; Nakano, Y; Sakai, K; Shinohara, S; Takami, A; Takasugi, S; Uchino, K; Yamamoto, H | 1 |
Benhamou, Y; Comparon, C; Coppo, P; Galicier, L; Rebibou, JM | 1 |
Galstyan, GM; Kalinina, II; Klebanova, EE; Maschan, AA | 1 |
Baer, MR; Ding, J; Hess, JR; Zimrin, AB | 1 |
Cataland, SR; Kellett, ET; Li, H; Liu, J; Wu, HM; Wu, N; Yang, S | 1 |
de la Rubia Orti, JE; Espuny Miró, A; Rizo Cerdá, AM; Selvi Sabater, P | 1 |
Coppo, P; Froissart, A | 1 |
Huang, J; Jin, J; Ma, L; Mai, W; Mei, C; Meng, H; Qian, W; Ren, Y; Tong, H; Wei, J; Xu, W; Ye, L; Ye, X; Zhou, X | 1 |
Boctor, FN | 1 |
Cataland, SR; George, JN; Jin, M; Kraut, EH; Lin, S; Wu, HM | 1 |
Akaogi, T; Kawata, E; Kiyota, M; Kobayashi, Y; Kuroda, J; Sasaki, N; Taniwaki, M | 1 |
Caimi, TM; Morra, E; Mostarda, G; Nosari, A; Redaelli, R | 1 |
Austen, B; Hewamana, S; Johnson, S; Murray, J; Wilson, K | 1 |
Cohen, J; Gordon, B; Jhaveri, KD; Scheuer, A | 1 |
Casiello, M; Fiore, MG; Piscitelli, D; Rossi, R; Sanguedolce, F | 1 |
Asija, A; Nelson, J; Prasad, A; Shah, D | 1 |
Hidaka, S; Honda, K; Kobayashi, S | 1 |
Kessler, CS; Khan, BA; Lai-Miller, K | 1 |
Cetiner, M; Eskazan, AE; Ferhanoglu, B; Kara, E; Taninmis, H; Unsal, A; Yilmaz, M | 1 |
Bernuzzi, P; Corneo, R; Morra, E; Muti, G; Nosari, A; Pungolino, E; Rossi, V | 1 |
Allford, SL; Bird, JM; Marks, DI | 1 |
Amendola, G; Conte, ML; d'Urzo, G; Locatelli, F; Nobili, B; Perrotta, S; Rossi, F | 1 |
Ansell, SM; Dispenzieri, A; Elliott, MA; Gastineau, DA; Gertz, MA; Inwards, DJ; Lacy, MQ; Litzow, M; Micallef, IN; Nichols, WL; Plumhoff, EA; Tefferi, A | 1 |
Chao, CP; Cuccovia, B; Jayabose, S; Levendoglu-Tugal, O; Ozkayanak, MF; Sandoval, C | 1 |
Itälä, M; Remes, K | 1 |
Bockmeyer, CL; Claus, RA; Deigner, HP; Kaufmann, R; Kentouche, K; Lösche, W; Oberle, V; Sieber, MW | 1 |
Balasubramanian, M; Brodsky, I; Crilley, P; Gupta, S; Kahn, SB; Sesok-Pizzini, D; Styler, M; Topolsky, D; Ttan, N; Ward, K | 1 |
Bennett, C; Zakarija, A | 1 |
Kiss, JE; Qu, L | 1 |
Cataland, SR; Ferketich, AK; George, JN; Jin, M; Kennedy, MS; Kraut, EH; Wu, HM | 1 |
Enami, T; Goto, D; Hayashi, T; Ito, S; Mamura, M; Matsumoto, I; Sugihara, M; Sumida, T; Suzuki, T; Tsutsumi, A; Yoshimi, A | 1 |
Cataland, SR; George, JN; Jin, M; Kennedy, MS; Kraut, EH; Lin, S; Wu, HM | 1 |
Takahashi, R | 1 |
Bradstock, KF; Gottlieb, D; Srivastava, A | 1 |
Clark, RE; Pettitt, AR | 1 |
Flanigan, MJ; Hochstetler, LA; Lager, DJ | 1 |
Heintz, B; Kierdorf, H; Maurin, N | 1 |
Bachman, WR; Brennan, JK | 1 |
Bertesi, M; Emilia, G; Longo, G; Messora, C | 1 |
Alonso-Pulpón, L; Camacho, C; Diez, JL; Expósito, C; González, A; Oteo, JF; Serrano-Fiz, S | 1 |
Miyoshi, T; Ono, M; Teshima, T | 1 |
Baldrati, L; Capponcini, C; Docci, D; Facchini, F; Feletti, C; Giudicissi, A | 1 |
Fenstermaker, R; Herzig, GP; Schriber, J; Tezcan, H; Zimmer, W | 1 |
Davis, JH; Hand, JP; Lawlor, ER; Yong, CK | 1 |
Choi, HK; Jo, SK; Kim, SW; Kwon, YJ; Lim, HE; Moon, JS; Pyo, HJ; Suh, IB; Won, NH; Yoon, SY | 1 |
Albertson, T; Allen, R; Follette, D; Katznelson, S; Roberts, P | 1 |
Landaw, EM; Paquette, RL; Tran, L | 1 |
Acker, MA; DeNofrio, D; Loh, E; Reynolds, C; Rook, AH; Rosengard, BR | 1 |
Miwa, A | 1 |
Kennedy, B; Pratt, G; Smith, G | 1 |
Suehiro, A | 1 |
Hirabayashi, N | 1 |
Chinnakotla, S; Fidler, ME; Hammeke, MD; Leone, JP; Tarantolo, S | 1 |
Hamaguchi, H; Nagata, K; Yamaguchi, M | 1 |
Crilley, P; Styler, M; Teruya, J; Topolsky, D; Verde, S | 1 |
Remuzzi, G; Ruggenenti, P | 1 |
15 review(s) available for cyclosporine and Purpura, Thrombotic Thrombocytopenic
Article | Year |
---|---|
Successful preventive treatment with cyclosporine in a patient with relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a case report and review of the literature.
Topics: ADAMTS13 Protein; Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Young Adult | 2022 |
Treatment of thrombotic thrombocytopenic purpura beyond therapeutic plasma exchange.
Topics: Acetylcysteine; ADAM Proteins; ADAMTS13 Protein; Bortezomib; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Humans; Plasma Exchange; Platelet Aggregation Inhibitors; Prognosis; Purpura, Thrombotic Thrombocytopenic; Recombinant Proteins; Recurrence; Risk; Rituximab; Splenectomy; Steroids; Treatment Outcome; Vincristine; von Willebrand Factor | 2015 |
Thrombotic thrombocytopenic purpura: a hematological emergency.
Topics: ADAM Proteins; ADAMTS13 Protein; Antibodies, Monoclonal, Murine-Derived; Autoimmune Diseases; Cyclosporine; Female; Glucocorticoids; Hemolytic-Uremic Syndrome; Humans; Immunologic Factors; Immunosuppressive Agents; Infections; Neoplasms; Plasma Exchange; Platelet Transfusion; Pregnancy; Pregnancy Complications, Hematologic; Prognosis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Rituximab | 2012 |
Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Purpura, Thrombotic Thrombocytopenic; Recurrence | 2013 |
Thrombotic thrombocytopenic purpura following stem cell transplantation.
Topics: Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic | 2002 |
Drug-induced thrombotic microangiopathy.
Topics: ADAM Proteins; ADAMTS13 Protein; Antibiotics, Antineoplastic; Cyclosporine; Endothelium, Vascular; Fibrinolytic Agents; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Mitomycin; Purpura, Thrombotic Thrombocytopenic; Quinine; Ticlopidine; Treatment Outcome | 2005 |
Thrombotic microangiopathy in transplantation and malignancy.
Topics: Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Transplantation; Neoplasms; Plasma Exchange; Prognosis; Purpura, Thrombotic Thrombocytopenic; Risk Factors; Tacrolimus; Treatment Outcome | 2005 |
[Drug-induced thrombotic thrombocytopenic purpura].
Topics: Antirheumatic Agents; Aspirin; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Penicillamine; Plasma; Plasma Exchange; Platelet Aggregation Inhibitors; Prognosis; Purpura, Thrombotic Thrombocytopenic; Ticlopidine | 2007 |
Thrombotic microangiopathy following bone marrow transplantation.
Topics: Anemia, Hemolytic; Bone Marrow Transplantation; Cyclosporine; Endothelium, Vascular; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Purpura, Thrombotic Thrombocytopenic | 1994 |
Transplant-associated thrombotic microangiopathy: the role of IgG administration as initial therapy.
Topics: Adult; Capillaries; Cyclosporine; Female; Hemolytic-Uremic Syndrome; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Middle Aged; Organ Transplantation; Purpura, Thrombotic Thrombocytopenic | 1994 |
[Thrombotic microangiopathy in hematopoietic stem cell transplantation].
Topics: Antineoplastic Agents; Cyclosporine; Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Purpura, Thrombotic Thrombocytopenic; Transplantation Conditioning | 1998 |
[Thrombotic thrombocytopenic purpura: pathophysiology and treatment].
Topics: Bone Marrow Transplantation; Cyclosporine; Humans; Immunosuppressive Agents; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic | 2000 |
[Thrombotic microangiopathy (TMA) (1). TMA in the target organs of graft-versus-host disease].
Topics: Anemia, Hemolytic; Bone Marrow Transplantation; Cyclosporine; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Purpura, Thrombotic Thrombocytopenic; Syndrome | 2000 |
Questionable efficacy of plasma exchange for thrombotic thrombocytopenic purpura after bone marrow transplantation.
Topics: Adult; Bone Marrow Transplantation; Contraindications; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunosuppressive Agents; Infections; Leukemia; Male; Middle Aged; Multiple Organ Failure; Plasma Exchange; Platelet Transfusion; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Treatment Failure | 2001 |
Thrombotic microangiopathies.
Topics: Adult; Child; Cyclosporine; Endothelium, Vascular; Female; Genetic Predisposition to Disease; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Infections; Kidney; Kidney Transplantation; Microcirculation; Neoplasms; Plasma Exchange; Platelet Aggregation Inhibitors; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic; Thrombosis | 1991 |
4 trial(s) available for cyclosporine and Purpura, Thrombotic Thrombocytopenic
Article | Year |
---|---|
Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Autoantibodies; Biomarkers; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Purpura, Thrombocytopenic, Idiopathic; Purpura, Thrombotic Thrombocytopenic; Remission Induction; Secondary Prevention; Young Adult | 2008 |
Treatment with short-term, high-dose cyclosporin A in children with refractory chronic idiopathic thrombocytopenic purpura.
Topics: Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Male; Mycoses; Platelet Count; Purpura, Thrombotic Thrombocytopenic | 2003 |
An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura.
Topics: ADAM Proteins; ADAMTS13 Protein; Adrenal Cortex Hormones; Adult; Autoantibodies; Chemotherapy, Adjuvant; Cyclosporine; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Prospective Studies; Purpura, Thrombotic Thrombocytopenic; Remission Induction | 2007 |
Long-term salvage treatment by cyclosporin in refractory autoimmune haematological disorders.
Topics: Adult; Aged; Aged, 80 and over; Anemia, Hemolytic, Autoimmune; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Salvage Therapy; Treatment Outcome | 1996 |
37 other study(ies) available for cyclosporine and Purpura, Thrombotic Thrombocytopenic
Article | Year |
---|---|
Preemptive cyclosporin A in immune-mediated thrombotic thrombocytopenic purpura.
Topics: ADAMTS13 Protein; Autoantibodies; Cyclosporine; Humans; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab | 2023 |
[Treatment of thrombotic thrombocytopenic purpura].
Topics: Acetylcysteine; Bortezomib; Child; Cyclosporine; Humans; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Rituximab | 2021 |
Intravenous immunoglobulin as salvage therapy for refractory thrombotic thrombocytopenic purpura.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Registries; Retrospective Studies; Salvage Therapy; Splenectomy; Treatment Outcome; Vidarabine; Vincristine; Young Adult | 2018 |
Diagnostic and prognostic values of ADAMTS13 activity measured during daily plasma exchange therapy in patients with acquired thrombotic thrombocytopenic purpura.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Aged; Clinical Enzyme Tests; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Prednisone; Prognosis; Purpura, Thrombotic Thrombocytopenic; Sensitivity and Specificity; Treatment Outcome | 2015 |
[Cyclosporin-induced thrombotic thrombocytopenic purpura. Report of three cases].
Topics: Adolescent; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic | 2016 |
Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.
Topics: ADAMTS13 Protein; Adolescent; Adult; Aged; Antibodies, Monoclonal; China; Cyclosporine; Disease Management; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Rituximab; Vincristine; Young Adult | 2016 |
Tacrolimus (FK506) associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in lung transplant salvage with a plasmapheresis and cyclosporin.
Topics: ADAM Proteins; ADAMTS13 Protein; Cyclosporine; Female; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Lung Transplantation; Middle Aged; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Tacrolimus | 2006 |
Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome.
Topics: Adult; Anti-Inflammatory Agents; Blood Cell Count; Bone Marrow; Cyclosporine; Female; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes; Plasma Exchange; Prednisolone; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic | 2008 |
Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura.
Topics: Cyclosporine; Humans; Immunosuppressive Agents; Purpura, Thrombotic Thrombocytopenic; Recurrence; Remission Induction; Treatment Outcome | 2009 |
Intestinal perforation secondary to haematopoietic stem cell transplant associated thrombotic microangiopathy.
Topics: Adult; Cyclosporine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Inflammation; Intestinal Perforation; Lymphoma, Follicular; Male; Microcirculation; Purpura, Thrombotic Thrombocytopenic; Transplantation Conditioning | 2009 |
Treatment of refractory thrombotic thrombocytopenic purpura using multimodality therapy including splenectomy and cyclosporine.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Combined Modality Therapy; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Methylprednisolone Hemisuccinate; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Treatment Outcome | 2009 |
Unusual case report of thrombotic microangiopathy of the small bowel following liver transplantation, a possible immunosuppressant-induced disease with histological and ultrastructural findings.
Topics: Colic; Cyclosporine; Humans; Immunosuppressive Agents; Intestinal Diseases; Intestine, Small; Liver Transplantation; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Tacrolimus | 2009 |
Acquired thrombotic thrombocytopenic purpura associated with reversible severe renal failure requiring hemodialysis.
Topics: Antibodies, Monoclonal, Murine-Derived; Combined Modality Therapy; Cyclosporine; Female; Glucocorticoids; Humans; Immunologic Factors; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Renal Insufficiency; Rituximab; Severity of Illness Index; Treatment Outcome | 2012 |
Successful treatment with cyclosporine of thrombotic thrombocytopenic purpura refractory to corticosteroids and plasma exchange.
Topics: Adult; Cyclosporine; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Treatment Outcome | 2011 |
Late response to cyclosporine in refractory thrombotic thrombocytopenic purpura.
Topics: Adult; Cyclosporine; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Steroids; Treatment Outcome | 2002 |
Posttransplantation thrombotic thrombocytopenic purpura: a single-center experience and a contemporary review.
Topics: ADAM Proteins; ADAMTS13 Protein; Adolescent; Adult; Anti-Inflammatory Agents; Bone Marrow Transplantation; Cyclosporine; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Incidence; Male; Metalloendopeptidases; Methylprednisolone; Middle Aged; Peripheral Blood Stem Cell Transplantation; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Risk Factors; Tissue Donors; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; von Willebrand Factor | 2003 |
Use of vincristine and cyclosporine in childhood thrombotic thrombocytopenic purpura.
Topics: Adolescent; Child; Cyclosporine; Female; Humans; Male; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Time Factors; Treatment Outcome; Vincristine | 2003 |
Excellent response of refractory life-threatening thrombotic thrombocytopenic purpura to cyclosporine treatment.
Topics: Adult; Antineoplastic Agents, Phytogenic; Blood Platelets; Cyclosporine; Female; Humans; Immunosuppressive Agents; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Treatment Outcome; Vincristine | 2004 |
Transcriptional regulation of ADAMTS13.
Topics: ADAM Proteins; ADAMTS13 Protein; Adrenal Cortex Hormones; Anti-Bacterial Agents; Binding Sites; Cell Line; Cyclosporine; DNA, Complementary; Doxycycline; Endothelium, Vascular; Exons; Gene Expression Regulation; Humans; Immunosuppressive Agents; Inflammation; Interleukin-1; Interleukin-6; Liver; Metalloendopeptidases; Promoter Regions, Genetic; Purpura, Thrombotic Thrombocytopenic; Reverse Transcriptase Polymerase Chain Reaction; RNA; Steroids; Transcription, Genetic; Tumor Necrosis Factor-alpha; von Willebrand Factor | 2005 |
Thrombotic thrombocytopenic purpura induced by cyclosporin a after allogeneic bone marrow transplantation treated by red blood cell exchange transfusion: a case report.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Erythrocyte Transfusion; Female; Humans; Purpura, Thrombotic Thrombocytopenic; Transplantation, Homologous | 2005 |
Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13.
Topics: ADAM Proteins; Antibody Formation; Blood Chemical Analysis; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2007 |
Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity.
Topics: ADAM Proteins; ADAMTS13 Protein; Adult; Combined Modality Therapy; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Recurrence; Treatment Outcome | 2007 |
Diffuse alveolar haemorrhage associated with microangiopathy after allogeneic bone marrow transplantation.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Transplantation; Cyclosporine; Endothelium, Vascular; Fatal Outcome; Female; Hemolytic-Uremic Syndrome; Hemorrhage; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lung Diseases; Lymphoma, Non-Hodgkin; Male; Plasma; Plasmapheresis; Platelet Transfusion; Pulmonary Alveoli; Purpura, Thrombotic Thrombocytopenic; Respiratory Insufficiency; Transplantation, Homologous; Vascular Diseases | 1995 |
Cyclosporine for thrombotic thrombocytopenic purpura.
Topics: Cyclosporine; Humans; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic | 1993 |
Refractory thrombotic thrombocytopenic purpura treated with cyclosporine.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Danazol; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukins; Methylprednisolone Hemisuccinate; Plasma Exchange; Pregnancy; Pregnancy Complications, Hematologic; Purpura, Thrombotic Thrombocytopenic; Splenectomy; Vincristine | 1996 |
Microangiopathic hemolytic anemia secondary to cyclosporine therapy in a heart and liver transplant recipient.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Capillaries; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Polyarteritis Nodosa; Postoperative Complications; Purpura, Thrombotic Thrombocytopenic; Skin | 1996 |
Cyclosporine-related encephalopathy following allogeneic bone marrow transplantation.
Topics: Bone Marrow Transplantation; Brain Diseases; Cyclosporine; Humans; Immunosuppressive Agents; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Transplantation, Homologous | 1996 |
Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura in a patient with Behçet's disease treated with cyclosporin.
Topics: Adult; Behcet Syndrome; Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Purpura, Thrombotic Thrombocytopenic | 1997 |
Severe cerebellar swelling and thrombotic thrombocytopenic purpura associated with FK506.
Topics: Adult; Bone Marrow Transplantation; Cerebellum; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Purpura, Thrombotic Thrombocytopenic; Tacrolimus; Transplantation, Homologous | 1998 |
Successful use of cyclosporine A in the treatment of refractory thrombotic thrombocytopenic purpura.
Topics: Adolescent; Chronic Disease; Cyclosporine; Humans; Male; Plasma Exchange; Platelet Count; Purpura, Thrombotic Thrombocytopenic; Recurrence | 1998 |
A case of Wegener's granulomatosis complicated by diffuse pulmonary hemorrhage and thrombotic thrombocytopenic purpura.
Topics: Aged; Cyclosporine; Female; Granulomatosis with Polyangiitis; Hemorrhage; Humans; Lung Diseases; Prednisolone; Purpura, Thrombotic Thrombocytopenic | 1998 |
Cyclosporine A-associated thrombotic thrombocytopenic purpura following lung transplantation.
Topics: Aged; Cyclosporine; Emphysema; Female; Humans; Immunosuppressive Agents; Lung Neoplasms; Lung Transplantation; Lymphangioleiomyomatosis; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic | 1998 |
Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.
Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Glucocorticoids; Graft vs Host Disease; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Treatment Outcome | 1998 |
Rescue photochemotherapy for the treatment of acute cardiac rejection in the absence of cyclosporine maintenance therapy.
Topics: Acute Disease; Adult; Biopsy; Cyclosporine; Drug Therapy, Combination; Endocardium; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Myocardium; Photochemotherapy; Photopheresis; Purpura, Thrombotic Thrombocytopenic | 1998 |
Cyclosporin neurotoxicity after chemotherapy. Case had features of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.
Topics: Cyclosporine; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Microcirculation; Purpura, Thrombotic Thrombocytopenic; Renal Circulation | 1999 |
Clopidogrel-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in a kidney/pancreas transplant recipient.
Topics: Adult; Clopidogrel; Coronary Disease; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Hemolytic-Uremic Syndrome; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Pancreas Transplantation; Plasmapheresis; Platelet Aggregation Inhibitors; Purpura, Thrombotic Thrombocytopenic; Ticlopidine | 2000 |
[Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine A and splenectomy].
Topics: Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Plasma Exchange; Purpura, Thrombotic Thrombocytopenic; Remission Induction; Splenectomy | 2000 |